|
Comparison of Effectiveness Between PL and PRP on Knee Osteoarthritis: a Prospective,Randomized,Placebo-controlled Trial
RECRUITINGPhase 4Sponsored by National Taiwan University Hospital
Actively Recruiting
PhasePhase 4
SponsorNational Taiwan University Hospital
Started2018-05-15
Est. completion2027-05-14
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT03734900
Summary
This study will focus on grade I to III knee osteoarthritis by randomized controlled trials which comparing the effectiveness between placebo, autologous platelet rich plasma and autologous platelet lysate injections.
Eligibility
Age: 50 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria: * 50 to 80 years old * Study Subjects must be willing to sign Informed Consent to participate in the study * In the past month, at least seven consecutive days in the squat, standing, walking or going up and down the stairs, the most serious degree of visual analogy of the knee pain (Visual Analogue Scale) is greater than or equal to 40 (the most pain is 100, not painful is 0) * Morning joint stiffness is less than 30 minutes * X-ray:Grade 1-3 radiographic OA as defined by the K-L classification Exclusion Criteria: * Knee instability * The knee joint is obviously deformed (\> 5 degree valgus or varus deviation on X-ray) * Clinical diagnosed as Pes tendinitis, Chondromalacia * Taking NSAIDs or steroids (including oral and injection) within one week * Using anticoagulant drugs for a long time * Platelet count is less than 150,000 / UL, or coagulation disorders, prothrombin time (PT value) is less than 11 seconds or greater than 16 seconds * Leukemia, sepsis, platelet dysfunction or other blood related diseases * tumors, infections or the trauma before the same site * Pregnancy
Conditions2
ArthritisOsteoarthritis (OA) of the Knee
Interventions2
Related trials
- Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis — Istituto Ortopedico Rizzoli
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 4
SponsorNational Taiwan University Hospital
Started2018-05-15
Est. completion2027-05-14
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT03734900